Apollon Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$840K Sell
4,184
-94
-2% -$19.4K 0.01% 663
2025
Q4
$884K Buy
4,278
+553
+15% +$111K 0.02% 626
2025
Q3
$668K Sell
3,725
-139
-4% -$23.7K 0.01% 728
2025
Q2
$623K Sell
3,864
-392
-9% -$62.4K 0.01% 713
2025
Q1
$724K Buy
4,256
+32
+0.8% +$5.56K 0.02% 606
2024
Q4
$702K Buy
4,224
+1,371
+48% +$234K 0.02% 627
2024
Q3
$491K Sell
2,853
-989
-26% -$164K 0.01% 732
2024
Q2
$592K Sell
3,842
-13
-0.3% -$1.95K 0.02% 618
2024
Q1
$593K Buy
3,855
+1,465
+61% +$223K 0.02% 636
2023
Q4
$378K Sell
2,390
-79
-3% -$11.3K 0.01% 756
2023
Q3
$361K Sell
2,469
-327
-12% -$49.8K 0.02% 639
2023
Q2
$428K Buy
2,796
+385
+16% +$60K 0.02% 643
2023
Q1
$374K Sell
2,411
-15
-0.6% -$2.36K 0.02% 614
2022
Q4
$374K Sell
2,426
-25
-1% -$3.69K 0.03% 598
2022
Q3
$323K Sell
2,451
-196
-7% -$27.5K 0.03% 573
2022
Q2
$359K Sell
2,647
-100
-4% -$13.8K 0.03% 516
2022
Q1
$410K Sell
2,747
-1,489
-35% -$220K 0.03% 513
2021
Q4
$686K Buy
+4,236
New +$685K 0.05% 389

Other funds holding FBT